STUDY: FIRST TIME STROKE SURVIVORS HAVE SUBSTANTIAL IMMEDIATE AND ACCELERATED LONG TERM-COGNITIVE DECLINE New evidence points to vascular risk factors exerting impact on cognitive function years before stroke onset
SEGMENT
Filmed in Sydney | January 2025
New evidence from the Centre for Healthy Brain Ageing (CHeBA) indicates that older adults who experience a stroke for the first time will have substantial immediate and accelerated long term-cognitive decline.
Stroke is a leading cause of disability and dementia globally, with projections indicating a continued rise in both prevalence and burden. The new research, published in October 2024 in JAMA Network Open, looked at finding out exactly how a stroke impacts a person’s cognitive abilities.
Stroke occurs when blood flow to part of the brain is blocked or reduced, causing damage to brain cells. Previous research from the Centre has shown that more than a third of stroke survivors’ ability to think, remember and make decisions is significantly disadvantaged after stroke, with clear deficits in cognition or vascular dementia present.
Vascular dementia, the second most common type of dementia, is caused by reduced blood flow to the brain. The research, led by biostatistician and Research Associate Jess Lo, addressed many unanswered questions about this dementia type, which is yet to be studied as extensively as Alzheimer’s disease.
“Although we do experience changes to our brain functioning over time and as we age, certain medical conditions can potentially speed up these changes, which may lead to cognitive impairment or dementia,” says Lo.
The research analysed data from 14 studies that followed community dwelling older adults without a history of stroke or dementia, with an average age of 73 over many years, tracking their health and cognitive abilities. The studies, part of the CHeBA-led international Cohort Studies of Memory in an International Consortium (COSMIC), span 11 countries including Australia, Brazil, France and the US.
With data from 20,860 participants, the researchers identified people who experienced their first stroke during the study period.
The research also found that individuals who had a history of diabetes, hypertension, high cholesterol, cardiovascular disease, depression, smoked or were APOE4 carriers exhibited significantly faster cognitive decline before any stroke.
Senior author on the paper and Co-Director of the Centre for Healthy Brain Ageing (CHeBA), Professor Perminder Sachdev, said that this global collaborative study highlights the significant and lasting negative impact of stroke on brain cognition.
“Our findings can help clinicians better plan for the ongoing needs of stroke survivors who are at risk of disability and a lower quality of life,” said Professor Sachdev.
You Might also like
-
Message from former Australian Health Minister Hon Greg Hunt
The Honourable Greg Hunt served in the Australian Government as Minster for Health and Aged Care from 2017, previously as Industry, Innovation and Science Minister and before that the Environment Minister.
Elected as the Member for Flinders in 2001, Greg announced his retirement from politics late 2021 and in 2022, ahead of the Federal Election, having completed 20 years as a public servant.
Australian Health Journal recently caught up with Greg in a relaxed interview at his home in the Mornington Peninsula, Victoria to hear how a 9 month sabbatical has allowed him to focus on family, fitness and future. This has even included some “brutal spin cycle classes!”.
-
Observations in diagnosis and treatment of oral cancer over the past 45 years
Peter Thomson is Academic Head of Dentistry and Professor of Oral & Maxillofacial Sciences in the College of Medicine & Dentistry at James Cook University, Australia. A UK and Australian specialist in Oral & Maxillofacial Surgery and Oral Medicine, he qualified BDS from Manchester University and MBBS from Newcastle upon Tyne, gaining Fellowships in Dental Surgery from the Royal College of Surgeons of England, Ireland and Glasgow and a Fellowship in Surgery from Edinburgh, specializing in Head & Neck Oncology.
-
Ruth Zionzee – Distinguished Life Fellow
ACN Ruth Zionzee – Distinguished Life Fellow